Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks

90Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

Abstract

Despite the clinical application of adeno-associated virus (AAV) gene therapy, the titration of viral stocks has not yet been standardized. This complicates the comparison of viral stocks between laboratories. Functional titering of AAV is time-consuming, requires the manipulation of hazardous material, and often has a high degree of variability. We established an optimized real-time quantitative polymerase chain reaction (RQ-PCR) titration assay to determine viral titers and compared it with a functional green fluorescent protein (GFP)-based titration method. With a combination of improved lysis procedures and RQ-PCR protocols we could decrease the intraexperimental coefficient of variation (CV) from 0.24 ± 0.03 to 0.042 ± 0.004 and the interexperimental CV from 0.34 ± 0.06 to 0.093 ± 0.028 following functional and RQ-PCR-based titration, respectively. This low variability conforms to even the strictest quality standards required, for example, in clinical laboratories. The highly standardized titration by RQ-PCR described here will be especially advantageous for groups working on AAV-based gene therapy in a good manufacturing practice setting.

Cite

CITATION STYLE

APA

Veldwijk, M. R., Topaly, J., Laufs, S., Hengge, U. R., Wenz, F., Zeller, W. J., & Fruehauf, S. (2002). Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks. Molecular Therapy, 6(2), 272–278. https://doi.org/10.1006/mthe.2002.0659

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free